Severe Photosensitivity Reaction to Vandetanib

被引：17

作者：

Chang, Chih-Hsiang ^{[1
]}

Chang, John W. C. ^{[2
]}

Hui, Chung-Yee ^{[1
]}

Yang, Chih-Hsun ^{[1
]}

机构：

[1] Chang Gung Mem Hosp & Univ, Dept Dermatol, Taipei, Taiwan

[2] Chang Gung Mem Hosp & Univ, Dept Hematol Oncol, Taipei, Taiwan

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 27期

关键词：

ZD6474; INHIBITOR;

D O I：

10.1200/JCO.2009.21.8479

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：E114 / E115

页数：2

共 5 条

[1] ZD6474 - clinical experience to date [J].

Heymach, JV .

BRITISH JOURNAL OF CANCER, 2005, 92 (Suppl 1) :S14-S20

[2] Clinical evaluation of ZD6474, an orally active inhibitor of VEGF and EGF receptor signaling, in patients with solid, malignant tumors [J].

Holden, SN ;

Eckhardt, SG ;

Basser, R ;

de Boer, R ;

Rischin, D ;

Green, M ;

Rosenthal, MA ;

Wheeler, C ;

Barge, A ;

Hurwitz, HI .

ANNALS OF ONCOLOGY, 2005, 16 (08) :1391-1397

[3] A Multicenter phase II trial of ZD6474, a vascular endothelial growth factor receptor-2 and epidermal growth factor receptor tyrosine kinase inhibitor, in patients with previously treated metastatic breast cancer [J].

Miller, KD ;

Trigo, JM ;

Wheeler, C ;

Barge, A ;

Rowbottom, J ;

Sledge, G ;

Baselga, J .

CLINICAL CANCER RESEARCH, 2005, 11 (09) :3369-3376

[4] Drug-induced cutaneous photosensitivity - Incidence, mechanism, prevention and management [J].

Moore, DE .

DRUG SAFETY, 2002, 25 (05) :345-372

[5] ZD6474 - a novel inhibitor of VEGFR and EGFR tyrosine kinase activity [J].

Ryan, AJ ;

Wedge, SR .

BRITISH JOURNAL OF CANCER, 2005, 92 (Suppl 1) :S6-S13

← 1 →